AMAG ADVANCE MAGNETIC

Advanced Magnetics, Inc. is a developer of superparamagnetic iron oxide nanoparticles used in pharmaceutical products. The Company is dedicated to the development and commercialization of its nanoparticle technology for use in therapeutic iron compounds to treat anemia, as well as novel imaging agents to aid in the diagnosis of cardiovascular disease and cancer. The Company has two approved products: Feridex I.V. and GastroMARK, and two product candidates: ferumoxytol and Combidex

Company: ADVANCE MAGNETIC
NASDAQ Symbol: AMAG

Industry: Diagnostic Substances
Employees: 36

AMAG Stock Quotes

AMAG ADVANCE MAGNETIC Intraday Chart

AMAG ADVANCE MAGNETIC Intraday Chart is provided by MSN Money!

Stock quotes and profiles for companies in Diagnostic Substances similar to AMAG ADVANCE MAGNETIC

QLTI QLT Inc.

LEXG Lexicon Genetics Incorporated

THLD Threshold Pharmaceuticals, Inc.

AVAN Avant Immunotherapeutics, Inc.

ICGN Icagen, Inc.

QDEL Quidel Corporation

PARD PONIARD PHARMACEUTIC

GLGC Gene Logic Inc.

ISTA ISTA Pharmaceuticals, Inc.

HGSI Human Genome Sciences, Inc.

Stock history for AMAG ADVANCE MAGNETIC

AMAG Pharmaceuticals, DryShips and Acergy ADR lead small-cap volume in pre-market (SmallCapInvestor.com)
AMAG Pharmaceuticals Inc. , DryShips Inc. and Acergy ADR are among the most actively traded companies in Tuesday's trading among companies with market... Read

Premarket roundup: AMAG Pharma, apparel retailers (AP)
Analysts are mixed on how much shares of AMAG Pharmaceuticals Inc. could rise following the company's announcement that it faces another regulatory delay on its anemia drug candidate. Read

AMAG gets FDA request for more information on drug (AP)
AMAG Pharmaceuticals Inc. said late Monday the Food and Drug Administration asked for more information on the anemia drug candidate ferumoxytol before considering it for approval. Read

Ahead of the Bell: AMAG Pharmaceuticals (AP)
Analysts are mixed on how much shares of AMAG Pharmaceuticals Inc. could rise following the company's announcement that it faces another regulatory delay on its anemia drug candidate. Read

AMAG PHARMACEUTICALS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Stat (EDGAR Online)
Read

AMAG Pharmaceuticals, Inc. Receives Complete Response Letter from the FDA for Ferumoxytol Call scheduled for 8:30 am ET today (CCBN)
Read

AMAG Pharmaceuticals, Inc. to Present at the 27th Annual J.P. Morgan Healthcare Conference (Business Wire)
Read

Five Healthcare Stocks Positioned for a Happy New Year (Seeking Alpha)
Read

Finance news provided by Yahoo! Finance.